首页> 美国卫生研究院文献>Open Access Journal of Urology >Acotiamide hydrochloride hydrate added to combination treatment with an α-blocker and a cholinergic drug improved the QOL of women with acute urinary retention: case series
【2h】

Acotiamide hydrochloride hydrate added to combination treatment with an α-blocker and a cholinergic drug improved the QOL of women with acute urinary retention: case series

机译:水合乙酰甲酰胺盐酸盐与α受体阻滞剂和胆碱能药物联合治疗可改善女性急性尿women留的QOL:案例系列

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acute urinary retention is the most common urological emergency. To resolve this emergency, urethral catheterization is performed. If the procedure fails and permanent transurethral catheterization is required, the patient’s quality of life is significantly affected. Therefore, catheter-free treatment is the ideal goal of therapy for patients with acute urinary retention. Especially, for women, placement of a catheter poses a cosmetic problem. Therefore, the aim of this study was to treat female patients who had already received urapidil/distigmine bromide with acotiamide. Acotiamide was administered at a dose of 100 mg three times daily for 2 weeks, and the outcome of trial without catheter was evaluated. Only female patients were enrolled for this study. Treatment proved successful and all patients become catheter free.
机译:急性尿retention留是最常见的泌尿外科急症。为了解决这种紧急情况,需要进行尿道导管插入术。如果操作失败,并且需要永久性经尿道插管,则将严重影响患者的生活质量。因此,无导管治疗是急性尿retention留患者理想的治疗目标。特别地,对于女性,导管的放置带来了美容问题。因此,本研究的目的是治疗已经接受尿嘧啶胺/溴氰菊酯和烟酰胺酰胺治疗的女性患者。每天3次以100 mg剂量的乙酰甲酰胺给药,持续2周,并评估不使用导管的试验结果。仅女性患者参加了本研究。治疗被证明是成功的,所有患者都无需导管。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号